Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies

Journal of Virology(2023)10.1128/jvi.01635-22Source: DataRank Database

Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies is a research paper published in Journal of Virology (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.86)OA: hybridTopics (55)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Lindsay Wieczorek ORCID,Eric Sanders‐Buell ORCID,Michelle Zemil ORCID,Sebastian Molnar ORCID,Gina Donofrio

Live enrichment

PubMed:36749076 PMC:PMC9973046 OpenAlex:https://openalex.org/W4319332798

U.S. Department of Defense

Grant: W81XWH-18-2-0040

Swiss National Science Foundation

Grant: P3SMP3_148406/1

Swiss National Science Foundation

Grant: 148406

Characterization of viral phosphorylation involved in maturation of virions of human and simian immunodeficiency viruses

NIAID NIH HHS

Grant: P30 AI064518

FWCI

0.86

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

hybridLicense: cc-by

journalhttp://dx.doi.org/10.1128/jvi.01635-22

HYBRIDhttp://dx.doi.org/10.1128/jvi.01635-22

publisherhttp://dx.doi.org/10.1128/jvi.01635-22

publisherhttps://journals.asm.org/doi/pdf/10.1128/jvi.01635-22

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36749076

Fields of Study

HIV Research and TreatmentImmune Cell Function and InteractionT-cell and B-cell ImmunologyMedicineBiology0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

Antibody FormationHumansHIV AntibodiesHIV-1HIV Infectionsenv Gene Products, Human Immunodeficiency VirusAntibodies, Neutralizing

Keywords

Neutralizing antibodyAntibodyHeterologousBiologyViral loadClearanceVirologyNeutralizationAntibody-dependent cell-mediated cytotoxicityHuman immunodeficiency virus (HIV)ImmunologyMedicineGeneGeneticsHIV-1ADCCCrf01_aeViral Load Set PointV1v2Neutralization BreadthAutologous NeutralizationMonoclonal antibodyRegulatory T Cell Development and FunctionUrologyHIV InfectionsHIV AntibodiesAntibodiesHumansImmunology and MicrobiologyFOS: Clinical medicineenv Gene Products, Human Immunodeficiency VirusLife SciencesHIVAntibodies, NeutralizingFOS: Biological sciencesAntibody FormationPathogenesis and ImmunityHuman Immunodeficiency Virus/Acquired Immunodeficiency SyndromeImmune ResponsesNatural Killer Cells in Immunity

Sustainable Development Goals

SDG 0: Good health and well-being